CHEK will be looking for FDA approval by early 2023. US Pivotal Study will take place in 2022.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
